Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Stoke Therapeutics Inc (NQ: STOK ) 12.63 +0.27 (+2.18%) Streaming Delayed Price Updated: 12:45 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Stoke Therapeutics Inc < Previous 1 2 3 4 5 6 Next > Stoke Therapeutics Presents Zorevunersen Data Showing Substantial Reductions in Seizures and Improvements in Multiple Measures of Cognition and Behavior That Support the Potential for Disease Modification in Dravet Syndrome September 10, 2024 From Stoke Therapeutics, Inc. Via Business Wire Stoke Therapeutics Appoints Eric Olson, MS, MBA as Chief Business Officer September 04, 2024 From Stoke Therapeutics, Inc. Via Business Wire A Closer Look at 5 Analyst Recommendations For Stoke Therapeutics June 28, 2024 Via Benzinga Analyst Expectations For Stoke Therapeutics's Future May 06, 2024 Via Benzinga Assessing Stoke Therapeutics: Insights From 6 Financial Analysts April 04, 2024 Via Benzinga Stoke Therapeutics to Present at Upcoming Investor Conferences in September September 03, 2024 From Stoke Therapeutics, Inc. Via Business Wire Stoke Therapeutics to Present Encore Data at the 15th European Epilepsy Congress that Demonstrate the Potential for Zorevunersen to be the First Disease-Modifying Medicine for the Treatment of Dravet Syndrome September 03, 2024 From Stoke Therapeutics, Inc. Via Business Wire Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) August 16, 2024 From Stoke Therapeutics, Inc. Via Business Wire Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates August 07, 2024 From Stoke Therapeutics, Inc. Via Business Wire Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) July 16, 2024 From Stoke Therapeutics, Inc. Via Business Wire Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday June 24, 2024 Via Benzinga Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) June 18, 2024 From Stoke Therapeutics, Inc. Via Business Wire Stoke Therapeutics to Present at Upcoming Investor Conferences in June June 03, 2024 From Stoke Therapeutics, Inc. Via Business Wire Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) May 17, 2024 From Stoke Therapeutics, Inc. Via Business Wire STOK Stock Earnings: Stoke Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 06, 2024 STOK stock results show that Stoke Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates May 06, 2024 From Stoke Therapeutics, Inc. Via Business Wire Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer April 29, 2024 From Stoke Therapeutics, Inc. Via Business Wire Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer April 17, 2024 From Stoke Therapeutics, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's After-Market Session April 05, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session April 04, 2024 Via Benzinga Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference April 04, 2024 From Stoke Therapeutics, Inc. Via Business Wire Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering March 27, 2024 From Stoke Therapeutics, Inc. Via Business Wire 12 Health Care Stocks Moving In Wednesday's Intraday Session March 27, 2024 Via Benzinga What's Going On With Stoke Therapeutics Stock Tuesday? March 26, 2024 After the market close on Tuesday, Stoke Therapeutics announced a proposed underwritten public offering of up to $75 million of its common stock. The company also intends to grant the underwriters a... Via Benzinga Stoke Therapeutics Announces Proposed Public Offering March 26, 2024 From Stoke Therapeutics, Inc. Via Business Wire Crude Oil Moves Lower; TD SYNNEX Earnings Top Estimates March 26, 2024 U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 80 points on Tuesday. The Dow traded up 0.21% to 39,397.20 while the NASDAQ rose 0.23% to 16,421.62. The S&P 500... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 26, 2024 Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session March 26, 2024 Via Benzinga Dow Gains 100 Points; McCormick Posts Upbeat Results March 26, 2024 U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 100 points on Tuesday. The Dow traded up 0.25% to 39,413.30 while the NASDAQ rose 0.27% to 16,448.55. The S&P 500... Via Benzinga Topics Stocks Exposures US Equities Stoke Therapeutics Inc. (NASDAQ: STOK) Near the Top of Equities by Percentage Gain on 3/26 March 26, 2024 Via Investor Brand Network < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
